Growth Metrics

Pacific Biosciences Of California (PACB) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 22.14%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.14%
Dec 31, 2025 31.97%
Sep 30, 2025 33.30%
Jun 30, 2025 21.43%
Mar 31, 2025 17.70%
Dec 31, 2024 1.12%
Jun 30, 2024 -51.16%
Mar 31, 2024 -48.51%
Dec 31, 2023 -59.21%
Sep 30, 2023 -54.11%
Jun 30, 2023 -20.61%
Mar 31, 2023 -48.22%
Dec 31, 2022 -49.35%
Sep 30, 2022 -54.01%
Jun 30, 2022 -51.09%
Mar 31, 2022 -46.16%
Dec 31, 2021 -18.65%
Jun 30, 2021 -2.72%
Mar 31, 2021 -7.16%
Dec 31, 2020 10.95%
Sep 30, 2020 0.06%
Jun 30, 2020 -22.92%
Mar 31, 2020 86.82%
Dec 31, 2019 -12.11%
Sep 30, 2019 -2.83%
Jun 30, 2019 2.40%
Mar 31, 2019 -7.69%
Dec 31, 2018 -198.47%
Sep 30, 2018 3.49%
Jun 30, 2018 -24.60%
Mar 31, 2018 7.75%
Dec 31, 2017 -9.57%
Sep 30, 2017 -41.96%
Jun 30, 2017 2.03%
Mar 31, 2017 -0.84%
Dec 31, 2016 3.98%
Sep 30, 2016 -41.75%
Jun 30, 2016 -4.80%
Mar 31, 2016 -4.87%
Dec 31, 2015 66.04%
Sep 30, 2015 3.68%
Jun 30, 2015 31.79%
Mar 31, 2015 -11.31%
Dec 31, 2014 -1.30%
Sep 30, 2014 36.06%
Jun 30, 2014 23.89%
Mar 31, 2014 21.39%
Dec 31, 2013 28.00%
Sep 30, 2013 36.82%